The role of phosphodiesterase 5 inhibitors in the treatment of lower urinary tract symptoms: an evidence based review. Portuguese Journal of Family Medicine and General Practice, [S. l.], v. 32, n. 4, p. 257–64, 2016. DOI: 10.32385/rpmgf.v32i4.11826. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/11826. Acesso em: 17 apr. 2026.